Please assess the completion status of the following clinical trial:

Trial Title: Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* females~* with at least 10 cm from the lateral reticular veins of the leg or thigh of the leg~* clinical classification of chronic venous disease C1(mild venous disease),~* minimum age of 18 year-old and maximum age 69 year-old~* agreement with the study~* signing the free and informed consent ( IC)~* not use anticoagulant drugs .~Exclusion Criteria:~* male~* varicose disease in any quantity or location with clinical classification of chronic venous disease different of C1(mild venous disease)~* restrict mobility~* arterial insufficiency~* be allergic to any substance that may be related to the study drugs~* any cause of dermatitis on application site~* free of comorbidities clinically serious as diabetes mellitus, heart failure, respiratory failure, uncontrolled hypertension with medication, and uncontrolled hypothyroidism~* pregnancy~* previous deep vein thrombosis (DVT)~* family history of DVT~* thrombophilia~* do not agree with the search terms

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 69 Years
- Healthy Volunteers: f

Study Arms:
- Polidocanol with Glucose (Type: ACTIVE_COMPARATOR): An application session 0.2% Polidocanol + 70% Glucose to treat reticular veins of the lower limb selected, with a maximum volume of 5 ml.
- Glucose (Type: ACTIVE_COMPARATOR): An application session 75% Glucose to treat reticular veins of the lower limb selected, with a maximum volume of 5ml.

Based on this trial design, predict the completion outcome and termination type (if applicable).